Log in
Enquire now
‌

US Patent 9062289 Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells

Patent 9062289 was granted and assigned to Asterias Biotherapeutics on June, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Asterias Biotherapeutics
Asterias Biotherapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
90622890
Patent Inventor Names
Mohammad Hassanipour0
Joseph D. Gold0
Date of Patent
June 23, 2015
0
Patent Application Number
114719160
Date Filed
June 20, 2006
0
Patent Primary Examiner
‌
Thaian N. Ton
0
Patent abstract

The present application describes the new methods for the differentiation of primate pluripotent stem cells into cardiomyocyte-lineage cells. The methods utilize sequential culturing of the primate pluripotent stem cells in certain growth factors to produce cardiomyocyte-lineage cells. In certain embodiments of the invention, the population of cells produced by the sequential culturing is further enriched for cardiomyocyte-lineage cells so as to produce a higher percentage of those cells.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9062289 Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us